Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$2.21 - $2.89 $4,420 - $5,780
-2,000 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$2.39 - $3.5 $4,780 - $7,000
2,000 New
2,000 $6,000
Q1 2021

May 24, 2021

SELL
$2.86 - $4.33 $5,720 - $8,660
-2,000 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$2.93 - $4.3 $5,860 - $8,600
2,000 New
2,000 $7,000

About Aptinyx Inc.


  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.